Synthesis and evaluation of some pyrazolo[3,4-d]pyridazinones and analogues as PDE 5 inhibitors potentially useful as peripheral vasodilator agents

被引:20
作者
Dal Piaz, V
Castellana, MC
Vergelli, C
Giovannoni, MP
Gavaldà, A
Segarra, V
Beleta, J
Ryder, H
Palacios, JM
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, I-50121 Florence, Italy
[2] Almirall Prodesfarma Res Ctr, Barcelona 08024, Spain
关键词
pyrazolopyridazinones; PDE5; inhibitors;
D O I
10.1080/1475636021000008494
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of pyrazolo[3,4-d]pyridazinones and analogues, potentially useful as peripheral vasodilators, were synthesized and evaluated as inhibitors of PDE5 extracted from human platelets. Several of them showed IC50 values in the range 0.14-1.4 muM. A good activity and selectivity profile versus PDE6 was found for compound 11e (6-benzyl-3-methyl-1-isopropyl-4-phenylpyrazolo[3,4-d]pyridazin-7(6H)-one). Structure-activity relationship studies demonstrated the essential role played by the benzyl group at position-6 of the pyrazolopyridazine system. Other types of pyridazinones fused with five and six membered heterocycles (pyrrole, isoxazole, pyridine and dihydropyridine), as well as some open models were prepared and evaluated. Besides the pyrazole, the best fused systems proved to be isoxazole and pyridine.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 20 条
[1]  
BARNETTE MS, 1998, J PHARMACOL EXP THER, P105
[2]  
BEAVO JA, 1994, MOL PHARMACOL, V46, P399
[3]   CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE INHIBITION BY IMIDAZOPYRIDINES - ANALOGS OF SULMAZOLE AND ISOMAZOLE AS INHIBITORS OF THE CGMP SPECIFIC PHOSPHODIESTERASE [J].
COATES, WJ ;
CONNOLLY, B ;
DHANAK, D ;
FLYNN, ST ;
WORBY, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1387-1392
[4]   Inhibitors of types I and V phosphodiesterase: Elevation of cGMP as a therapeutic strategy [J].
Czarniecki, M ;
Ahn, HS ;
Sybertz, EJ .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 :61-70
[5]   Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies [J].
Dal Piaz, V ;
Giovannoni, MP .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (05) :463-480
[6]  
DALPIAZ V, 1989, SYNTHESIS-STUTTGART, P213
[7]  
DALPIAZ V, 1991, J PHARM SCI, V80, P341
[8]   Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors [J].
DalPiaz, V ;
Giovannoni, MP ;
Castellana, C ;
Palacios, JM ;
Beleta, J ;
Domenech, T ;
Segarra, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) :1417-1421
[9]   NEW SYNTHETIC APPROACH TO PYRAZOLO [3,4-D] PYRIDAZIN-7(6H)-ONE RING-SYSTEM [J].
DALPIAZ, V ;
CICIANI, G ;
GIOVANNONI, MP ;
TURCO, G .
HETEROCYCLES, 1989, 29 (08) :1595-1600
[10]  
DALPIAZ V, 1991, HETEROCYCLES, V32, P1173